JP2007518825A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518825A5
JP2007518825A5 JP2006551442A JP2006551442A JP2007518825A5 JP 2007518825 A5 JP2007518825 A5 JP 2007518825A5 JP 2006551442 A JP2006551442 A JP 2006551442A JP 2006551442 A JP2006551442 A JP 2006551442A JP 2007518825 A5 JP2007518825 A5 JP 2007518825A5
Authority
JP
Japan
Prior art keywords
group
poam
alkyl
moiety
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006551442A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518825A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002478 external-priority patent/WO2005070921A1/en
Publication of JP2007518825A publication Critical patent/JP2007518825A/ja
Publication of JP2007518825A5 publication Critical patent/JP2007518825A5/ja
Pending legal-status Critical Current

Links

JP2006551442A 2004-01-23 2005-01-24 複素環式アルキルカルボキサミドプロパノン酸類のポリエチレングリコール抱合体類 Pending JP2007518825A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53857304P 2004-01-23 2004-01-23
PCT/US2005/002478 WO2005070921A1 (en) 2004-01-23 2005-01-24 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids

Publications (2)

Publication Number Publication Date
JP2007518825A JP2007518825A (ja) 2007-07-12
JP2007518825A5 true JP2007518825A5 (https=) 2009-04-09

Family

ID=34807197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551442A Pending JP2007518825A (ja) 2004-01-23 2005-01-24 複素環式アルキルカルボキサミドプロパノン酸類のポリエチレングリコール抱合体類

Country Status (5)

Country Link
US (1) US7595318B2 (https=)
EP (1) EP1706399A1 (https=)
JP (1) JP2007518825A (https=)
CA (1) CA2554188A1 (https=)
WO (1) WO2005070921A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI418346B (zh) * 2004-07-08 2013-12-11 伊蘭製藥公司 包括聚合物部分之多價vla-4拮抗劑
US8030328B2 (en) 2005-05-20 2011-10-04 Elan Pharmaceuticals, Inc. Imidazolone phenylalanine derivatives
SG163565A1 (en) * 2005-07-08 2010-08-30 Elan Pharm Inc Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds
TW200817369A (en) * 2006-05-22 2008-04-16 Elan Pharm Inc Preparation of polymer conjugates of therapeutic, agricultural and food additive compounds
JP2010521465A (ja) * 2007-03-12 2010-06-24 ネクター セラピューティックス 複合体のデノボ合成
WO2015048819A1 (en) 2013-09-30 2015-04-02 The Regents Of The University Of California Anti-alphavbeta1 integrin compounds and methods
CA2981371A1 (en) 2015-03-10 2016-09-15 The Regents Of The University Of California Anti-alphavbeta1 integrin inhibitors and methods of use
KR20210018820A (ko) 2018-05-04 2021-02-18 안티센스 테라퓨틱스 엘티디 치료 용도 및 방법
KR102659859B1 (ko) 2018-10-30 2024-04-25 길리애드 사이언시즈, 인코포레이티드 알파4β7 인테그린의 억제를 위한 화합물
AU2019373242B2 (en) 2018-10-30 2023-07-13 Gilead Sciences, Inc. Compounds for inhibition of alpha 4 beta 7 integrin
EP4541422A3 (en) 2018-10-30 2025-06-25 Gilead Sciences, Inc. Quinoline derivatives as alpha4beta7 integrin inhibitors
CN112969700B (zh) 2018-10-30 2024-08-20 吉利德科学公司 作为α4β7整合素抑制剂的咪唑并吡啶衍生物
KR102908219B1 (ko) 2019-08-14 2026-01-08 길리애드 사이언시즈, 인코포레이티드 알파 4 베타 7 인테그린의 저해용 화합물
US20220023227A1 (en) * 2020-07-24 2022-01-27 Georgia Southern University Research And Service Foundation, Inc. Systems and methods for forming nanocapsules by pulsed electrospraying
WO2022266498A1 (en) * 2021-06-17 2022-12-22 Nektar Therapeutics Histidine-selective polymer reagents

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604103A (en) * 1982-07-30 1986-08-05 Chevron Research Company Deposit control additives--polyether polyamine ethanes
US5510332A (en) * 1994-07-07 1996-04-23 Texas Biotechnology Corporation Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor
WO1996001644A1 (en) 1994-07-11 1996-01-25 Athena Neurosciences, Inc. Inhibitors of leukocyte adhesion
EP1001764A4 (en) * 1997-05-29 2005-08-24 Merck & Co Inc HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
US6489300B1 (en) * 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
AR016133A1 (es) * 1997-07-31 2001-06-20 Wyeth Corp Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
US6436904B1 (en) * 1999-01-25 2002-08-20 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
GEP20053477B (en) * 1999-08-13 2005-03-25 Biogen Inc Cell Adhesion Inhibitors and Pharmaceutical Compositions Containing Them
EP1251866A1 (en) * 2000-01-24 2002-10-30 Schering Corporation Combination of temozolomide and pegylated interferon-alpha for treating cancer
EP1253923A1 (en) * 2000-01-28 2002-11-06 Biogen, Inc. Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
EP1326594A2 (en) * 2000-10-18 2003-07-16 Schering Corporation Ribavirin-pegylated interferon alfa hcv combination therapy
WO2003011226A2 (en) * 2001-08-01 2003-02-13 Smithkline Beecham Corporation Products and drug delivery vehicles
WO2003041642A2 (en) * 2001-11-09 2003-05-22 Enzon, Inc. Polymeric thiol-linked prodrugs employing benzyl elimination systems
US6608076B1 (en) * 2002-05-16 2003-08-19 Enzon, Inc. Camptothecin derivatives and polymeric conjugates thereof
CA2514125A1 (en) * 2003-01-24 2004-08-12 Elan Pharmaceuticals, Inc. Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
AR044927A1 (es) * 2003-06-25 2005-10-12 Elan Pharm Inc Metodos y composiciones para tratar la artritis reumatoidea
TWI418346B (zh) * 2004-07-08 2013-12-11 伊蘭製藥公司 包括聚合物部分之多價vla-4拮抗劑
US8030328B2 (en) * 2005-05-20 2011-10-04 Elan Pharmaceuticals, Inc. Imidazolone phenylalanine derivatives
SG163565A1 (en) * 2005-07-08 2010-08-30 Elan Pharm Inc Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds

Similar Documents

Publication Publication Date Title
JP2007518825A5 (https=)
JP2008517926A5 (https=)
CN114430739A (zh) Egfr抑制剂、组合物及其制备方法
CN114430740A (zh) Egfr抑制剂、组合物及其制备方法
JP2019534260A5 (https=)
RU2376287C2 (ru) Производные бензамида, способ их получения и их применение, фармацевтическая композиция и способ обеспечения ингибирующего действия по отношению к hdac
JP2014521653A5 (https=)
JP2004534010A5 (https=)
JP2020505396A5 (https=)
JP2012503018A5 (https=)
JP2004535447A5 (https=)
JP2003521537A5 (https=)
MY124864A (en) Adenosine a2a receptor antagonists
JP2002543185A5 (https=)
JP2009541268A5 (https=)
CA2585053A1 (en) Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
JP2011509309A5 (https=)
JP2020505395A5 (https=)
JP2015526448A5 (https=)
JP2013505969A5 (https=)
JP2006503082A5 (https=)
CA2474738A1 (en) N-phenyl-2-pyrimidine-amine derivatives
JP2009542721A5 (https=)
JP2004534774A5 (https=)
JP2011509301A5 (https=)